099430 — Bio Plus Co Cashflow Statement
0.000.00%
- KR₩347bn
- KR₩391bn
- KR₩66bn
- 58
- 31
- 37
- 35
Annual cashflow statement for Bio Plus Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 9,703 | 10,673 | 20,708 | 27,422 | 17,510 |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | 3,920 | 8,274 | 5,478 | 2,603 | 6,543 |
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -4,590 | -6,892 | -14,713 | -16,475 | -5,033 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Net Change in Other Assets & Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 10,043 | 13,352 | 13,359 | 16,040 | 22,290 |
| Capital Expenditures | -1,096 | -15,358 | -6,694 | -21,572 | -96,647 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | -481 | -7,277 | -60,436 | 43,301 | 12,283 |
| Sale of Business | |||||
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Change in Net Intangibles | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -1,577 | -22,634 | -67,130 | 21,728 | -84,364 |
| Financing Cash Flow Items | — | -2,376 | -15 | -3,940 | -350 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 4,827 | 34,045 | 30,659 | -10,212 | 53,719 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 13,146 | 25,035 | -22,677 | 27,653 | -7,331 |